AbCellera Biologics Inc. Share Price

AbCellera Biologics Inc. Share Price

NASDAQ: ABCL | Mid Cap
$13.09
-$0.55 (-4.07%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

AbCellera Biologics Inc. Stock Performance

Open
$13.43
Prev. Close
$13.64
Circuit Range
N/A
Day Range
$13.02 - $13.82
Year Range
$2.75 - $15.02
Volume
1,84,708
Average Traded
$13.34

AbCellera Biologics Inc. Share Price Today

As of 30 October 2026, AbCellera Biologics Inc.'s share price is $13.09. The stock opened at $13.43, compared to its previous close of $13.64. During today's trading session, AbCellera Biologics Inc.'s share price traded between $13.02 and $13.82, with an average price of $13.42. Over the past 52 weeks, the stock has recorded a high of $15.02 and a low of $2.75. In terms of performance, AbCellera Biologics Inc.'s share price has risen by 214.92% over the last six months and is up 136.19% on a year-on-year basis.

AbCellera Biologics Inc. Share Price Chart

Line chart of the AbCellera Biologics Inc. price trend over the selected period. The price fell overall, ranging from 13.02 to 13.82, ending at 13.09.
$13.02$13.82
L
Show Current Price
H

AbCellera Biologics Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.91B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.51
Revenue (TTM)
$75.13B
Return On Equity (TTM)
-18.38%
Profit Margin
-194.88%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
2.96%

AbCellera Biologics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$8.96$44.85$8.32$4.05
Net Profit-$57.12-$8.95-$43.17-$55.43
Net Profit Margin-637.50%-19.96%-518.87%-1368.64%
Income ChangeN/A84.33%-382.35%-28.40%

AbCellera Biologics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$485.42$38.03$28.83$75.13
Net Profit$158.52-$146.40-$162.86-$146.41
Net Profit Margin32.66%-384.96%-564.90%-194.88%
Income ChangeN/A-192.35%-11.24%10.10%

About AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

AbCellera Biologics Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$14.57
$13.09
-10.37%
Sep 2026
$11.28
$14.61
+17.92%
Aug 2026
$5.68
$12.38
+116.90%
Jul 2026
$7.78
$5.71
-27.17%
Jun 2026
$6.13
$7.84
+26.86%
May 2026
$4.13
$6.18
+48.74%
Apr 2026
$3.53
$4.16
+18.88%
Mar 2026
$3.48
$3.50
-2.92%
Feb 2026
$3.56
$3.60
-0.55%
Jan 2026
$3.46
$3.62
+6.16%
Dec 2025
$3.58
$3.41
-8.82%
Nov 2025
$5.54
$3.74
-32.49%

ABCL Share Price FAQs